Intranasal immunization against viral infection using viral glyc

Details Intranasal immunization against viral infection using viral glyc Intranasal immunization against viral infection using viral glyc

1996-10-11

1998-12-01

Achutamurthy, Ponnathapura

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Fusion protein or fusion polypeptide

4242041, 4242111, 4242121, 4242141, 4352351, 4351721, 514 8, 530806, A61K 3900, A61K 39155, A61K 3912, C12N 700

Patent

active

058434518

ABSTRACT:
Method for immunizing against viral infection by administering intranasally an immunogenically effective amount of a viral envelope subunit vaccine comprising a glycoprotein complexed with a lipid.

REFERENCES:
patent: 3544680 (1970-12-01), Plotkin
patent: 3634587 (1972-01-01), Ament et al.
patent: 3927208 (1975-12-01), Zygraich et al.
patent: 3950512 (1976-04-01), Emery et al.
patent: 3953592 (1976-04-01), Peetermans
patent: 3962421 (1976-06-01), Neurath
patent: 3962422 (1976-06-01), Parks
patent: 3962423 (1976-06-01), Peetermans et al.
patent: 4110433 (1978-08-01), Purdy, III
patent: 4132775 (1979-01-01), Volenec et al.
patent: 4172124 (1979-10-01), Koprowski et al.
patent: 4196265 (1980-04-01), Koprowski et al.
patent: 4235871 (1980-11-01), Papabadjopoulos et al.
patent: 4261975 (1981-04-01), Fullerton et al.
patent: 4303644 (1981-12-01), Davis
patent: 4318903 (1982-03-01), Lobmann et al.
patent: 4337314 (1982-06-01), Oeschger et al.
patent: 4344935 (1982-08-01), Leclerc et al.
patent: 4356169 (1982-10-01), Simons et al.
patent: 4448765 (1984-05-01), Ash et al.
patent: 4512972 (1985-04-01), Schmidt-Ruppin
patent: 4522809 (1985-06-01), Adamowicz et al.
patent: 4552758 (1985-11-01), Murphy et al.
patent: 4663161 (1987-05-01), Mannino et al.
patent: 4790987 (1988-12-01), Compans et al.
patent: 5152981 (1992-10-01), Rones et al.
patent: 5223254 (1993-06-01), Paradiso et al.
patent: 5427782 (1995-06-01), Compans et al.
H. Ito and M. Matumoto, Japan. J. Exp. Med., 56 125-129 (1986).
O.G. Andzhaparidza et al., Voprosy Virusologil, "Soviet Progress in Virology", No. 1, 1987, Protective Effect of Virosomes, Containing Influenza Virus Antigens, After Intranasal Administration, pp. 112-114.
Miyamae et al., Microbiol. Immunol., 30(3): 213-223 (1986).
Waldman et al., Nature, 218: 594-95 (1968).
Waldman et al., Am. J. Epidem., 91(6): 575-584 (1970).
Fukumi et al., Dev. Biol. Stand., 33: 155-161 (1976).
Zahradnik et al., J. Med. Virol., 11: 277-285 (1983).
Petrescu et al., Rev. Roum. Med., 35: 307-314 (1984).
Wigley et al., New England J. Med., 283: 1250-1253 (1970).
Morein et al., Nature, 276: 715-718 (1978).
Morein et al., Vaccine, 3 83-93 (1985).
Ray et al., J. Infect. Dis., 152: 1219-30 (1985).
Morein et al., J. Gen. Virol., 64 1557-69 (1983).
Ray et al., Virology, 148: 232-36 (1986).
Ray et al., J. Gen. Virol., 68: 409-18 (1987).
G. Kohler and C. Milstein, Nature, 256: 495-497 (1975).
Kohler et al, European J. of Immunology, 6: 511-19 (1986).
Ray et al., Intransal Immunization with Envelope Glycoproteins of Human Parainfluenza Virus Type 3, pp. 1-26.
Chem. Abs., vol. 72, Abs. No. 53248e (1970).

Affiliated with

Also associated with

Rating

Intranasal immunization against viral infection using viral glyc does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Intranasal immunization against viral infection using viral glyc, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intranasal immunization against viral infection using viral glyc will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2393526